Substance / Medication

Dienestrol

Overview

Active Ingredient
dienestrol
RxNorm CUI
3368

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Clinical manifestations and evaluation of postmenopausal vulvovaginal atrophy.
Pérez-López Faustino R, Vieira-Baptista Pedro, Phillips Nancy et al. · Gynecol Endocrinol · 2021
PMID: 34036849Meta-Analysis
Comparison of the effect of hyaluronic acid and estrogen on atrophic vaginitis in menopausal women: A systematic review.
Najjarzadeh Maryam, Mohammad Alizadeh Charandabi Sakineh, Mohammadi Marzyeh et al. · Post Reprod Health · 2019
PMID: 30798700Meta-Analysis
Vaginal estrogen for genitourinary syndrome of menopause: a systematic review.
Rahn David D, Carberry Cassandra, Sanses Tatiana V et al. · Obstet Gynecol · 2014
PMID: 25415166Meta-AnalysisFull text (PMC)
Comparison of the Effects of Fenugreek Vaginal Cream and Ultra Low- Dose Estrogen on Atrophic Vaginitis.
Safary Maryam, Hakimi Sevil, Mobaraki-Asl Noushin et al. · Curr Drug Deliv · 2020
PMID: 32640956RCT
Noncandidal vaginitis: a comprehensive approach to diagnosis and management.
Neal Chemen M, Kus Lauren H, Eckert Linda O et al. · Am J Obstet Gynecol · 2020
PMID: 31513780Review
Genitourinary Syndrome of Menopause: Management Strategies for the Clinician.
Faubion Stephanie S, Sood Richa, Kapoor Ekta · Mayo Clin Proc · 2017
PMID: 29202940Review
Vaginal estrogen products in hormone receptor-positive breast cancer patients on aromatase inhibitor therapy.
Sulaica Elisabeth, Han Tiffany, Wang Weiqun et al. · Breast Cancer Res Treat · 2016
PMID: 27178335Review

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Dienestrol (substance)
SNOMED CT
126169003
UMLS CUI
C0012145
RxNorm CUI
3368

Clinical Data

This intervention maps to 3 entities in the Ltrl knowledge graph.

3
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.